Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

47 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Participant-guided development of bilingual genomic educational infographics for Electronic Medical Records and Genomics Phase IV study.
Casillan A, Florido ME, Galarza-Cornejo J, Bakken S, Lynch JA, Chung WK, Mittendorf KF, Berner ES, Connolly JJ, Weng C, Holm IA, Khan A, Kiryluk K, Limdi NA, Petukhova L, Sabatello M, Wynn J. Casillan A, et al. Among authors: mittendorf kf. J Am Med Inform Assoc. 2024 Jan 18;31(2):306-316. doi: 10.1093/jamia/ocad207. J Am Med Inform Assoc. 2024. PMID: 37860921 Free PMC article.
Feasibility of an electronic patient-facing cancer family history tool in medically underserved populations.
Feigelson HS, Mittendorf KF, Okuyama S, Porter KM, Bulkley J, Shuster E, Anderson KP, Gilmore MJ, Zepp JM, Kauffman TL, Lindberg NM, Muessig KR, Bellcross C, Ukaegbu C, Syngal S, Leo MC, Wilfond BS; Cancer Health Assessments Reaching Many (CHARM) Study. Feigelson HS, et al. Among authors: mittendorf kf. Genet Med Open. 2024 Jun 25;2:101860. doi: 10.1016/j.gimo.2024.101860. eCollection 2024. Genet Med Open. 2024. PMID: 39669603 Free PMC article.
Family history and cancer risk study (FOREST): A clinical trial assessing electronic patient-directed family history input for identifying patients at risk of hereditary cancer.
Mittendorf KF, Bland HT, Andujar J, Celaya-Cobbs N, Edwards C, Gerhart M, Hooker G, Hubert M, Jones SH, Marshall DR, Myers RA, Pratap S, Rosenbloom ST, Sadeghpour A, Wu RR, Orlando LA, Wiesner GL. Mittendorf KF, et al. Contemp Clin Trials. 2024 Oct 10;148:107714. doi: 10.1016/j.cct.2024.107714. Online ahead of print. Contemp Clin Trials. 2024. PMID: 39395532 Free article.
Prediction of Effectiveness and Toxicities of Immune Checkpoint Inhibitors Using Real-World Patient Data.
Lippenszky L, Mittendorf KF, Kiss Z, LeNoue-Newton ML, Napan-Molina P, Rahman P, Ye C, Laczi B, Csernai E, Jain NM, Holt ME, Maxwell CN, Ball M, Ma Y, Mitchell MB, Johnson DB, Smith DS, Park BH, Micheel CM, Fabbri D, Wolber J, Osterman TJ. Lippenszky L, et al. Among authors: mittendorf kf. JCO Clin Cancer Inform. 2024 Feb;8:e2300207. doi: 10.1200/CCI.23.00207. JCO Clin Cancer Inform. 2024. PMID: 38427922 Free PMC article.
Improving Care for Marginalized Populations at Risk for Hereditary Cancer Syndromes: Innovations that Expanded Reach in the CHARM Study.
Gilmore MJ, Knerr S, Kraft SA, Bulkley JE, Biesecker BB, Feigelson HS, Hunter JE, Jenkins CL, Kauffman TL, Lee SS, Liles EG, Mittendorf KF, Muessig KR, Porter KM, Rolf BA, Rope AF, Zepp JM, Anderson KP, Devine B, Joseph G, Leo MC, Goddard K, Wilfond BS. Gilmore MJ, et al. Among authors: mittendorf kf. Public Health Genomics. 2024;27(1):16-22. doi: 10.1159/000535610. Epub 2023 Dec 23. Public Health Genomics. 2024. PMID: 38142673 Free article. No abstract available.
47 results